Table 3 Bivariate analysis of indicator C and public opinion based on presence of licensed pharmacist
From: Public views of community pharmacy services during the COVID-19 pandemic: a national survey
Indicator C—dispensing, preparation, administration and distribution of medicines Answers retrieved for Yes responses (coded 1) reflecting patient satisfaction | Total | Customer feedback based on presence of licensed pharmacist | p value* | |||
|---|---|---|---|---|---|---|
N = 491 | No | Yes | I don’t know | |||
C1 | Consult the pharmacist before buying | 362 (81.9%) | 32 (8.8%) | 218 (60.2%) | 112 (31%) | 0.001 |
C2 | Buy drugs without prescription | 275 (62.2%) | 24 (8.7%) | 161 (58.5%) | 90 (32.8%) | 0.055 |
C3 | Type of drugs bought | |||||
C3.1 | Antibiotics | 116 (42.2%) | 14 (12.1%) | 71 (61.2%) | 31 (26.7%) | 0.081 |
C3.2 | Anti-hypertensive | 25 (9.1%) | 3 (12%) | 18 (72%) | 4 (16%) | 0.170 |
C3.3 | Cardiovascular | 11 (4%) | 1 (9%) | 6 (54.6%) | 4 (36.4%) | 0.961 |
C3.4 | Anxiolytics | 28 (10.2%) | 4 (14.3%) | 15 (53.6%) | 9 (32.1%) | 0.538 |
C3.5 | Gastro-intestinal | 46 (16.7%) | 8 (17.4%) | 28 (60.8%) | 10 (21.8%) | 0.033 |
C3.6 | Neurologic | 6 (2.2%) | 0 (0%) | 5 (83.4%) | 1 (16.6%) | 0.436 |
C3.7 | Respiratory | 23 (8.4%) | 3 (13%) | 10 (43.5%) | 10 (43.5%) | 0.302 |
C3.8 | Vitamins | 172 (62.5%) | 19 (11%) | 102 (59.3%) | 51 (29.7%) | 0.122 |
C3.9 | Hormone | 24 (8.7%) | 5 (20.8%) | 13 (54.2%) | 6 (25%) | 0.083 |
C3.10 | Local | 80 (29.1%) | 8 (10%) | 50 (62.5%) | 22 (27.5%) | 0.484 |
C3.11 | Cut smoking | 11 (4%) | 3 (27.3%) | 7 (63.6%) | 1 (9.1%) | 0.038 |
C3.12 | NSAIDs | 35 (12.7%) | 9 (25.7%) | 18 (51.5%) | 8 (22.8%) | 0.001 |
C4 | Informed by the pharmacist on prescription mistake | 232 (52.5%) | 21 (9%) | 148 (63.8%) | 63 (27.2%) | 0.056 |
C5 | Explain the purpose of generic | 356 (80.7%) | 34 (9.5%) | 207 (58.2%) | 115 (32.3%) | 0.003 |
C6 | Provided with enough information to adhere to treatment | 382 (86.3%) | 27 (7%) | 223 (58.4%) | 132 (34.6%) | 0.001 |
C7 | Provided you with enough information to reduce antimicrobial resistance | 330 (74.5%) | 20 (6%) | 193 (58.5%) | 117 (35.5%) | 0.001 |
C8 | Pharmacist take into account social background, educational level, cultural beliefs, literacy, native language and mental capacity | 247 (55.9%) | 20 (8.1%) | 158 (64%) | 69 (27.9%) | 0.002 |
C9 | Consult pharmacist for unusual responses to a medicine/ treatment | 313 (70.8%) | 18 (5.7%) | 188 (60.1%) | 107 (34.2%) | 0.001 |
C10 | Pharmacist involvement Referral to doctor/stops medication | 289 (92.6%) | 17 (5.9%) | 176 (60.9%) | 96 (33.2%) | 0.489 |
C11 | Monitoring and adjustment of therapy when needed | 200 (45.4%) | 9 (4.5%) | 120 (60%) | 71 (35.5%) | 0.007 |
C12 | Given education on using web-based information resources | 128 (29.1%) | 7 (5.4%) | 77 (60.2%) | 44 (34.4%) | 0.165 |
C13 | Average time spent on counselling 1–5 mn (not included in the scoring) | 311 (70.7%) | 32 (10.3%) | 176 (56.6%) | 103 (33.1%) | 0.102 |
C14 | Medications checked when prepared by an assistant before dispensing | 188 (45.3%) | 4 (2.2) | 127 (67.5%) | 57 (30.3%) | 0.001 |
C15 | The preparatory and dispensing area in the pharmacy are Clearly clean | 211 (49.6%) | 11 (5.2%) | 135 (63.9%) | 65 (30.9%) | 0.011 |
C16 | During COVID-19 went to the pharmacist as preferences for consult | 297 (67.1%) | 25 (8.5%) | 175 (58.9%) | 97 (32.6%) | 0.256 |